CERVICAL ADENOCARCINOMA
Clinical trials for CERVICAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 04:51 UTC
-
Major trial aims to boost survival for advanced gynecologic cancers
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called triapine to the standard treatment of radiation and chemotherapy (cisplatin) works better for women with newly diagnosed, advanced cervical or vaginal cancer. The goal is to see if the three-drug combination…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New study seeks better path for cervical cancer patients after radiation
Disease control OngoingThis study aims to find better ways to monitor and treat a specific type of cervical cancer (adenocarcinoma) after patients complete initial radiation and chemotherapy. It will follow 60 patients to see if detailed imaging and tissue analysis can help doctors decide the best next…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New immune therapy trial offers hope for women with Tough-to-Treat cervical cancer
Disease control OngoingThis study is testing whether the immunotherapy drug nivolumab can help control advanced cervical cancer that has returned or spread after initial treatment. It involves 26 women with persistent or recurrent cervical cancer who have already tried one prior chemotherapy regimen. T…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Yoga tested to ease side effects of cervical cancer treatment
Symptom relief OngoingThis study is testing whether yoga classes can help improve physical and emotional well-being for people with cervical cancer while they undergo chemotherapy and radiation. Researchers want to see if yoga reduces common treatment side effects like fatigue, anxiety, and pelvic pai…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC